True or False: All non-prescription pseudoephedrine and ephedrine must be sold in blister packs or unit doses.

The statement is true; all non-prescription pseudoephedrine and ephedrine must indeed be sold in blister packs or unit doses. This regulation is in place to help control the sale of these substances, which can be misused for the illegal production of methamphetamine. By requiring these medications to be sold in limited quantities and in blister packs, it allows pharmacies to monitor sales more effectively and reduce the risk of abuse. This requirement was established under the Combat Methamphetamine Epidemic Act of 2005, which set strict guidelines for the sale of products containing these ingredients to combat meth production.

The commitment to preventing misuse is reflected in the regulatory measures that necessitate this packaging, making it not just a guideline but a mandated practice for safety and legality. Thus, the accurate understanding of this regulation is crucial for anyone involved in pharmacy practice, particularly those working in states like Connecticut, where such laws are strictly enforced.